Combination therapy with thioguanine (NSC-752) and azaserine (NSC-742) for multiple myeloma.
D000328:Adult; D000368:Aged; D001377:Azaserine / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D013866:Thioguanine / Q000627:therapeutic use*
D001377:Azaserine; D013866:Thioguanine